References
- 1. Matias-Guiu X, Stewart CJR. Endometriosis-associated ovarian neoplasia. Pathology (Phila). 2018 Feb;50(2):190–204.10.1016/j.pathol.2017.10.006
- 2. Wei J-J, William J, Bulun S. Endometriosis and Ovarian Cancer: A Review of Clinical, Pathologic, and Molecular Aspects. Int J Gynecol Pathol. 2011 Nov;30(6):553–68.10.1097/PGP.0b013e31821f4b85
- 3. Mabuchi S, Sugiyama T, Kimura T. Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives. J Gynecol Oncol [Internet]. 2016 Jan 4 [cited 2020 Jun 29];27(3). Available from: https://doi.org/10.3802/jgo.2016.27.e3110.3802/jgo.2016.27.e31
- 4. Scott RB. Malignant changes in endometriosis. Obstet Gynecol. 1953 Sep;2(3):283–9.
- 5. Vercellini P, Viganò P, Buggio L, Makieva S, Scarfone G, Cribiù FM, et al. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:151–68.10.1016/j.bpobgyn.2018.01.017
- 6. LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol. 1988 Sep;19(9):1080–4.10.1016/S0046-8177(88)80090-X
- 7. Taniguchi F. New knowledge and insights about the malignant transformation of endometriosis. J Obstet Gynaecol Res. 2017 Jul;43(7):1093–100.10.1111/jog.1337228718209
- 8. Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1997 Mar;30(3):249–55.10.1046/j.1365-2559.1997.d01-592.x9088954
- 9. McCluggage WG. Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions. Histopathology. 2020 Jan;76(1):76–92.10.1111/his.1397031846535
- 10. Akbarzadeh-Jahromi M, Shekarkhar G, Sari Aslani F, Azarpira N, Heidari Esfahani M, Momtahan M. Prevalence of Endometriosis in Malignant Epithelial Ovarian Tumor. Arch Iran Med. 2015 Dec;18(12):844–8.
- 11. Fadare O, Parkash V. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary. Surg Pathol Clin. 2019 Jun 1;12(2):529–64.10.1016/j.path.2019.01.00931097114
- 12. Ñiguez Sevilla I, Machado Linde F, Marín Sánchez M del P, Arense JJ, Torroba A, Nieto Díaz A, et al. Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer. J Gynecol Oncol [Internet]. 2019 Apr 1 [cited 2020 May 3];30(4). Available from: https://doi.org/10.3802/jgo.2019.30.e6310.3802/jgo.2019.30.e63654310231074246
- 13. Czernobilsky B, Morris WJ. A Histologic Study of Ovarian Endometriosis with Emphasis on Hyperplastic and Atypical Changes. Obstet Gynecol. 1979 Mar;53(3):318–23.
- 14. Jd S. Prognostic Importance of Hyperplasia and Atypia in Endometriosis [Internet]. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 1996 [cited 2020 Jun 26]. Available from: https://pubmed.ncbi.nlm.nih.gov/8852439/
- 15. Bayramođlu H, Düzcan E. Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis. Pathol Oncol Res. 2001 Mar 1;7(1):33–8.10.1007/BF03032602
- 16. Oral E, Ilvan S, Tustas E, Korbeyli B, Bese T, Demirkiran F, et al. Prevalence of endometriosis in malignant epithelial ovary tumours. Eur J Obstet Gynecol Reprod Biol. 2003 Jul 1;109(1):97–101.10.1016/S0301-2115(03)00047-2
- 17. Aw K, Cv B, Wr H, Kd W. Ovarian Clear Cell Adenocarcinoma [Internet]. Gynecologic oncology. 1989 [cited 2020 Jun 25]. Available from: https://pubmed.ncbi.nlm.nih.gov/2920955/
- 18. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, et al. Ovarian Endometriosis Associated with Ovarian Carcinoma: A Clinicopathological and Immunohistochemical Study. Gynecol Oncol. 2000 May 1;77(2):298–304.10.1006/gyno.2000.576510785482